PHÂN TÍCH CHI PHÍ ĐIỀU TRỊ BỆNH PHỔI TẮC NGHẼN MẠN TÍNH THEO QUAN ĐIỂM NGƯỜI CHI TRẢ TẠI BỆNH VIỆN QUẬN 11

Abstract

Background: Chronic Obstructive Pulmonary Disease (COPD) is now becoming one of the medical problems leading to morbidity and mortality in the world as well as in Vietnam. Worldwide, researches on the treatment cost of COPD have been conducted in many countries and this is also one of the important to provide an overview of COPD treatment in Vietnam. Objectives: Analyzing the cost of treatment of chronic obstructive pulmonary disease from the payer perspective in district 11 hospital. Method: Cross-sectional descriptive study based on data collected from retrospective medical records and interviews with COPD inpatients and outpatients, meeting the selection criteria of  District 11 Hospital during the period from February to the end of May 2021. The research was conducted from the payers’ perspective including the health insurance payer and the patient, so direct (medical, non-medical) and indirect costs were assessed. Results: The monthly treatment cost increased gradually according to the severity of the disease with the value of 78,478.22; 214,303.02; 267,937.06 and VND 713,248.11 for stages from GOLD A to GOLD D; respectively. Thus, the cost of treatment for GOLD D stage is 9.09 times higher than that of GOLD A stage. In terms of structure, direct medical costs accounted for the highest proportion in all 4 disease stages, followed by indirect costs and non-medical direct costs was lowest. Conclusions: The study noted that the total monthly cost of treatment of COPD increased gradually with the severity of the disease and direct medical costs accounted for the highest proportion.